Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics

Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics

(2008) Wolfgang Maier et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Genetic Profiling of Genes from the Oxidative Stress Pathway Among North and South Indians

(2008) A. K. Tiwari et al.   HUMAN BIOLOGY

Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: Evidence of epistasis and competitive binding

(2008) K. E. Burdick et al.   HUMAN MOLECULAR GENETICS

Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions

(2008) P R Bakker et al.   MOLECULAR PSYCHIATRY

Strong association of de novo copy number mutations with sporadic schizophrenia

(2008) Bin Xu et al.   NATURE GENETICS

Neurexin 1α structural variants associated with autism

(2008) Jin Yan et al.   NEUROSCIENCE LETTERS

Pathway-based association analysis of genome-wide screening data suggest that genes associated with the ??-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia

(2008) Toshiya Inada et al.   Pharmacogenetics and Genomics

Genome-Wide Association Identifies a Common Variant in the Reelin Gene That Increases the Risk of Schizophrenia Only in Women

(2008) Sagiv Shifman et al.   PLoS Genetics

Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia

(2008) T. Walsh et al.   SCIENCE

Dysbindin (DTNBP1) and the Biogenesis of Lysosome-Related Organelles Complex 1 (BLOC-1): Main and Epistatic Gene Effects Are Potential Contributors to Schizophrenia Susceptibility

(2007) Derek W. Morris et al.   BIOLOGICAL PSYCHIATRY